EP MedSystems v. EchoCath rule 10b-5 securities liability
✍️ How to write this paper — tools & examples ▾
EP MedSystems v. EchoCath
Legal Analysis- EP MedSystems Inc. v. EchoCath Inc.
EP MedSystems Inc. v. EchoCath Inc. presents an opportunity to examine the required seven elements requisite to "recovering damages from a defendant under rule 10b-5 of section 10(b) pursuant to the SEC Act of 1934" (Textbook. N.D. PP. 895). Explication of these elements provides the fundamental analytical tool for reaching the conclusion that EchoCath did violate 10b-5 in its statements to MedSystems.
The underpinnings of the case stem from statements made by Frank DeBernardis, CEO of EchoCath, to executives of MedSystems from August 1996 through February 1997 (FindLaw.com. December 26, 2000. PP. 2). These representations offered assurances that EchoCath was in active and "imminent" negotiations with major medical companies for product licensing contracts. While legal counsel for EchoCath argued that the materiality of the statements was the critical issue in determining liability, a point with which the District Court agreed; the dismissal also relied on failure of MedSystems to "adequately plead scienter, reasonable reliance, and loss causation" (FindLaw.com. December 26, 2000. PP. 1).
Create your account
Always verify citation format against your institution’s current style guide requirements.